Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2014
01/01/2014CN102164928B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
01/01/2014CN102066376B Anhydrous crystal form of orvepitant maleate
01/01/2014CN102036987B Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof
01/01/2014CN102015641B 杂环化合物 Heterocyclic Compounds
01/01/2014CN101801375B Insulin sensitisers and methods of treatment
01/01/2014CN101679244B 5-membered heterocyclic derivative and use thereof for medical purposes
01/01/2014CN101589024B Novel minor groove binders
01/01/2014CN101528728B 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
01/01/2014CN101396346B 紫杉醇脂质复合物 Paclitaxel-lipid complexes
01/01/2014CN101264093B Compositions for increasing energy in vivo
01/01/2014CN101252927B Quinoline derivatives as antibacterial agents
12/2013
12/31/2013US8618305 Sorafenib dimethyl sulphoxide solvate
12/31/2013US8618304 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
12/31/2013US8618303 Pyrrolidine derivatives
12/31/2013US8618299 Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
12/31/2013US8618296 Arylethynyl derivatives
12/31/2013US8618292 Analogs of dehydrophenylahistins and their therapeutic use
12/31/2013US8618288 Pyrimidine compounds as serotonin receptor modulators
12/31/2013US8618287 Derivatives of triazines and uracils, their preparation and their application in human therapeutics
12/31/2013US8618285 Triazole derivatives
12/31/2013US8618284 Methods of preparing polymorphic form A of bazedoxifene acetate
12/31/2013US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
12/31/2013US8618270 Oligonucleotide analog and method for treating flavivirus infections
12/31/2013US8618269 Glycorandomization and production of novel novobiocin analogs
12/31/2013US8618266 Hasylated polypeptides
12/31/2013US8618258 Freeze-dried fibrin matrices and methods for preparation thereof
12/31/2013US8618178 Method and substances for treating T-cell mediated autoimmune diseases
12/31/2013US8618177 Method of treating pain caused by inflammation
12/31/2013US8618176 Methods and materials for the treatment of testosterone deficiency in men
12/31/2013US8618175 Ultrasound medical gel composition etherified hydroxyethylcellulose
12/31/2013US8618174 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
12/31/2013US8618172 Galenical formulations of organic compounds
12/31/2013US8618171 Encapsulated oil-in-water type emulsion composition
12/31/2013US8618170 Oral formulations of bis(thiohydrazide amides)
12/31/2013US8618169 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
12/31/2013US8618168 Self-emulsifying composition of OMEGA3 fatty acid
12/31/2013US8618167 Methods of attenuating cognitive deficits with sulfonyl fluorides
12/31/2013US8618166 Methods of treating mixed dyslipidemia
12/31/2013US8618165 Compounds
12/31/2013US8618164 Treatment of pain with topical diclofenac compounds
12/31/2013US8618163 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
12/31/2013US8618161 Fluorescent polymeric materials containing lipid soluble rhodamine dyes
12/31/2013US8618159 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/31/2013US8618158 Therapeutic agents
12/31/2013US8618157 Pharmaceutical formulation
12/31/2013US8618156 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
12/31/2013US8618155 Small-molecule modulators of Trp-p8 activity
12/31/2013US8618154 LXR modulators
12/31/2013US8618153 Hepatitis C virus inhibitors
12/31/2013US8618152 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
12/31/2013US8618151 Inhibitors of HCV NS5A
12/31/2013US8618150 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators
12/31/2013US8618149 Inhibition of biofilms in plants with imidazole derivatives
12/31/2013US8618148 Use of telmisartan for the prevention and treatment of vascular headache
12/31/2013US8618146 Epothilone compound formulations
12/31/2013US8618145 Small molecular compounds capable of accelerating proliferation of stem cells and use thereof
12/31/2013US8618144 Pyrrolidine-derived beta 3 adrenergic receptor agonists
12/31/2013US8618143 Selective neuronal nitric oxide synthase inhibitors with azole substituents
12/31/2013US8618142 Process for the preparation of roflumilast
12/31/2013US8618141 Aryl ureas with angiogenesis inhibiting activity
12/31/2013US8618140 P38 MAP kinase inhibitors
12/31/2013US8618139 Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
12/31/2013US8618138 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/31/2013US8618136 Methods for the treatment of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
12/31/2013US8618135 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects
12/31/2013US8618134 Method and composition for treating a serotonin receptor-mediated condition
12/31/2013US8618133 Aralkyl alcohol pyridine derivative compounds and the use thereof as medicaments for treating depression
12/31/2013US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
12/31/2013US8618131 Biphenyl derivatives
12/31/2013US8618130 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
12/31/2013US8618129 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
12/31/2013US8618127 Methods and compositions for alleviating stuttering
12/31/2013US8618126 Antiparisitic dihydroazole compounds and compositions comprising same
12/31/2013US8618125 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
12/31/2013US8618124 Heterobifunctional polymeric bioconjugates
12/31/2013US8618123 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
12/31/2013US8618122 Compound having acidic group which may be protected, and use thereof
12/31/2013US8618121 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
12/31/2013US8618120 Synergistic combinations of VR-1 antagonists and COX-2 inhibitors
12/31/2013US8618119 Fused cyanopyridines and the use thereof
12/31/2013US8618118 Remedy for migraine headache
12/31/2013US8618117 Amino-heterocyclic compounds
12/31/2013US8618116 Deuterium-enriched pyrimidine compounds and derivatives
12/31/2013US8618115 Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
12/31/2013US8618114 Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof
12/31/2013US8618113 Treatment for demyelinating disease
12/31/2013US8618112 Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1
12/31/2013US8618110 Compositions and methods for apoptosis modulators
12/31/2013US8618109 Piperazine-substituted benzothiophenes for treatment of mental disorders
12/31/2013US8618108 Methods of making cyclic, N-amino functional triamines
12/31/2013US8618107 Pyridone and aza-pyridone compounds and methods of use
12/31/2013US8618106 Protein kinase inhibitors
12/31/2013US8618104 Salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-A]pyrazine-1-carboxylate
12/31/2013US8618103 Inhibitors of JAK
12/31/2013US8618102 Bridged diazepan orexin receptor antagonists
12/31/2013US8618101 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
12/31/2013US8618100 Compounds with antibacterial activity against Clostridium
12/31/2013US8618099 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators
12/31/2013US8618098 Inhibitors of bruton's tyrosine kinase
12/31/2013US8618097 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 7860